Insurance coverage for physical ailments has expanded steadily, while coverage for mental health issues remains out of step ...

This is independent of pre-existing depressive or anxiety symptoms ... The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported ...

Neumora Therapeutics Inc.’s stock tumbled 80% Thursday, after the clinical-stage biotech said a late-stage trial of a ...

The prevalence of depression and anxiety among children, adolescents, and young adults in Southern California has increased ...

Medically reviewed by Dakari Quimby, PhD Male postpartum depression describes when a new father experiences postpartum ...

The changing landscape of health care during COVID-19 placed focus on increasing accessibility to mental health resources other than the emergency department (ED), with potential savings of over $ ...

Diagnoses of PTSD and anxiety disorders nearly doubled between 2019 and 2023, according to a new Defense Health Agency report ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

SPL-026 is under development for the treatment of major depressive disorder (MDD). The drug candidate is a psychedelic N,N-dimethyltryptamine (DMT) based medicine. It is administered through i ...

People explore different treatments and therapies to help with depression, and recently, researchers wanted to understand if ...